You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 7, July 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antibiotic Treatment of Children With Secretory Otitis Media

Amoxicillin-Clavulanate Is Superior to Penicillin V in a Double-blind Randomized Study

Jens Thomsen, MD, DMSc, FRCPS; Jørgen Sederberg-Olsen, MD; Viggo Balle, MD; Susanne Hartzen, MD

Arch Otolaryngol Head Neck Surg. 1997;123(7):695-699.


Abstract

Objective
To compare the effect of 2 different antimicrobial agents in the treatment of secretory otitis media (SOM).

Design
Prospective, double-blind, randomized study.

Patients
From a pool of 1450 children (aged 1-10 years) with SOM, defined by tympanometry as having type B or C2 tympanograms, 429 with SOM of at least 3 months' duration were included in the trial. After exclusion of 69 patients, the remaining 360 were evenly distributed among 4 treatment groups: penicillin V (Primcillin) for 14 and 28 days, and amoxicillin and clavulanate potassium in combination (Spektramox) for 14 and 28 days. Criteria for improvement was a change in tympanometric findings to type C1 or type A.

Results
The success rates were in favor of amoxicillin-clavulanate treatment for 28 days (P<.001) (rates for respective 14- and 28-day groups: penicillin V, 23% and 19%; amoxicillin-clavulanate, 31% and 44%). Antimicrobial therapy was more efficient (P<.001) in unilateral vs bilateral disease.

Conclusion
Antibiotic treatment improves the middle ear status in patients with SOM, and amoxicillin-clavulanate provides superior improvement to penicillin V.

Arch Otolaryngol Head Neck Surg. 1997;123:695-699



Author Affiliations

From the Department of Ear-Nose-Throat—Head and Neck Surgery, Gentofte University Hospital (Drs Thomsen and Balle), Gentofte; the Ear-Nose-Throat Clinic, Elsinore (Dr Sederberg-Olsen); and the Department of Clinical Microbiology, Herlev University Hospital, Herlev (Dr Hartzen), Denmark.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.